PIKAMAB Secures Critical Patent Rights to Develop Theragnostic Product, Lupus Therasight
10/15/2009 8:35:09 AM
MENLO PARK, Calif.--(BUSINESS WIRE)--PIKAMAB, a stratified medicine biopharmaceutical company, announced today that it has secured exclusive rights to two issued U.S. patents from Hospital for Special Surgery, New York. PIKAMAB is developing Lupus TherasightTM, a novel theragnostic product that will eventually help guide the drug development process and patient treatment protocols in the areas of lupus and lupus nephritis.
comments powered by